| Full atomistic model of prion structure and conversion G Spagnolli, M Rigoli, S Orioli, AM Sevillano, P Faccioli, H Wille, E Biasini, ... PLoS pathogens 15 (7), e1007864, 2019 | 124 | 2019 |
| Pharmacological inactivation of the prion protein by targeting a folding intermediate G Spagnolli, T Massignan, A Astolfi, S Biggi, M Rigoli, P Brunelli, ... Communications Biology 4 (1), 62, 2021 | 37 | 2021 |
| From system modeling to system analysis: The impact of resolution level and resolution distribution in the computer-aided investigation of biomolecules M Giulini, M Rigoli, G Mattiotti, R Menichetti, T Tarenzi, R Fiorentini, ... Frontiers in Molecular Biosciences 8, 676976, 2021 | 34 | 2021 |
| Modeling PrPSc Generation Through Deformed Templating G Spagnolli, M Rigoli, G Novi Inverardi, YB Codeseira, E Biasini, ... Frontiers in bioengineering and biotechnology 8, 590501, 2020 | 17 | 2020 |
| Ok Google, how could I design therapeutics against prion diseases? M Rigoli, G Spagnolli, P Faccioli, JR Requena, E Biasini Current Opinion in Pharmacology 44, 39-45, 2019 | 9 | 2019 |
| Communication pathways bridge local and global conformations in an IgG4 antibody T Tarenzi, M Rigoli, R Potestio Scientific Reports 11 (1), 23197, 2021 | 4 | 2021 |
| Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency M Rigoli, G Spagnolli, G Lorengo, P Monti, R Potestio, E Biasini, A Inga International Journal of Molecular Sciences 23 (14), 7960, 2022 | 2 | 2022 |
| In search of a dynamical vocabulary: a pipeline to construct a basis of shared traits in large-scale motions of proteins T Tarenzi, G Mattiotti, M Rigoli, R Potestio Applied Sciences 12 (14), 7157, 2022 | 2 | 2022 |
